T/NA 200 Pipe Insulation — G-I Holdings
Product Description
T/NA 200 was a pre-formed pipe insulation product manufactured by G-I Holdings (formerly GAF Corporation) during the period spanning approximately 1962 through 1972. Designed for use in industrial environments, the product was engineered to provide thermal insulation across a range of piping systems commonly found in manufacturing facilities, power generation plants, chemical processing operations, and other heavy industrial settings.
Pre-formed pipe insulation of this type was a standard component of mid-twentieth century industrial construction and maintenance. Products in this category were manufactured to fit standard pipe diameters, allowing workers to apply sections of insulation directly around pipe runs with relative efficiency. The T/NA 200 designation distinguished this product within G-I Holdings’ broader catalog of thermal and acoustic insulation materials. During the decade it was produced, demand for industrial pipe insulation remained high, driven by post-war industrial expansion and ongoing construction of large-scale processing and utility infrastructure across the United States.
G-I Holdings, through its predecessor corporate entities and affiliated operations, was a significant participant in the American insulation market during this era. The company produced a variety of construction and industrial products, several of which have since been identified in asbestos-related litigation and regulatory proceedings.
Asbestos Content
T/NA 200 pipe insulation contained chrysotile asbestos as a component of its formulation. Chrysotile, sometimes referred to as white asbestos, is a serpentine mineral fiber that was widely used in insulation manufacturing throughout the mid-twentieth century due to its heat resistance, tensile strength, and relative abundance as a mined commodity.
In pipe insulation products of this period, chrysotile asbestos fibers were commonly incorporated into the binding matrix or substrate material to improve thermal performance and structural integrity. The resulting product could withstand elevated operating temperatures while maintaining its shape around pipe surfaces. Manufacturers across the insulation industry relied on similar formulations during this era, and chrysotile remained the dominant asbestos fiber type in such applications.
The U.S. Environmental Protection Agency’s Asbestos Hazard Emergency Response Act (AHERA) framework and subsequent regulatory developments have long recognized chrysotile-containing insulation products as potential sources of hazardous fiber release, particularly when the materials are disturbed, cut, abraded, or degraded. All commercially used forms of asbestos, including chrysotile, are classified as known human carcinogens by the International Agency for Research on Cancer (IARC) and are subject to stringent occupational exposure limits under OSHA regulations codified at 29 C.F.R. § 1910.1001 and § 1926.1101.
How Workers Were Exposed
Industrial workers who handled, installed, maintained, or worked in proximity to T/NA 200 pipe insulation during its production years faced potential exposure to airborne asbestos fibers. Chrysotile-containing pipe insulation releases respirable fibers when its surface is disturbed — through cutting sections to length, fitting insulation around pipe joints and elbows, sanding or finishing cut edges, or removing existing insulation during repair and maintenance work.
Workers in industrial facilities where T/NA 200 was applied were at risk of inhaling these fibers over the course of routine job tasks. In many industrial environments of the 1960s and early 1970s, ventilation was limited, personal protective equipment was rarely provided for insulation work, and awareness of the health hazards associated with asbestos fiber inhalation was not consistently communicated to workers on the floor.
Exposure scenarios extended beyond the individuals directly applying or removing the insulation. In enclosed industrial settings — boiler rooms, pipe chases, mechanical equipment rooms, and processing floors — other workers present in the area during insulation activities could inhale fibers that became airborne and remained suspended in the work environment. This secondary or bystander exposure was a documented feature of asbestos-containing insulation use in industrial settings throughout this period.
Maintenance and repair work presented particular hazards. As pipe insulation aged, it became more friable — meaning it could be crumbled by hand pressure and released fibers more readily. Workers performing routine maintenance on insulated pipe systems, or removing deteriorated insulation prior to pipe repair, would have encountered materials in this more hazardous condition. OSHA’s current permissible exposure limit (PEL) for asbestos stands at 0.1 fibers per cubic centimeter of air as an eight-hour time-weighted average — a threshold that was frequently exceeded in pre-regulatory industrial environments where products like T/NA 200 were in active use.
Diseases associated with occupational asbestos exposure include mesothelioma (a cancer of the lining of the lungs, abdomen, or heart), lung cancer, asbestosis (a progressive fibrotic lung disease), and pleural disease. These conditions typically have latency periods of ten to fifty years between initial exposure and clinical diagnosis, meaning that workers exposed to T/NA 200 during its production years may only now be reaching the point of diagnosis.
Documented Legal Options
T/NA 200 is classified as a Tier 2 product for purposes of legal remedy, meaning that no dedicated asbestos bankruptcy trust fund has been established specifically to compensate claimants exposed to this product. Litigation against G-I Holdings and its affiliated corporate entities remains the primary avenue for individuals seeking compensation for asbestos-related illness connected to T/NA 200 exposure.
Litigation records document that G-I Holdings has been named as a defendant in asbestos personal injury proceedings involving its insulation products. Plaintiffs alleged that the company knew or should have known of the hazards associated with asbestos-containing products it manufactured and sold, and that it failed to adequately warn workers of those risks. Plaintiffs further alleged that this failure to warn, combined with the continued production and distribution of asbestos-containing insulation, directly contributed to occupational exposures resulting in serious illness and death.
Individuals who were employed in industrial settings where T/NA 200 was installed, maintained, or removed between 1962 and 1972 — and who have since been diagnosed with mesothelioma, lung cancer, asbestosis, or related conditions — may have viable legal claims. Because asbestos-related diseases have long latency periods, statutes of limitations in most jurisdictions run from the date of diagnosis rather than the date of exposure, preserving the right to file suit for many recently diagnosed individuals.
Consulting an attorney with documented experience in asbestos litigation is strongly recommended. A qualified attorney can assess the specific facts of a claimant’s employment history, identify all potentially liable parties (which may include product manufacturers, distributors, and premises owners in addition to G-I Holdings), and determine whether claims in multiple jurisdictions or against multiple defendants are warranted. In some cases, claims against asbestos bankruptcy trust funds established by other manufacturers may also be available in conjunction with litigation involving G-I Holdings.
Workers and surviving family members seeking legal guidance should gather and preserve any available employment records, union documentation, co-worker statements, and medical records that can support documentation of product-specific exposure.